Read More News 5 Value Stocks In The Industrials Sector By Benzinga Insights May 10, 10:40 AM What is a Value Stock? A value stock is traditionally defined in terms of how investors in the… AAL
Read More Biotech General Health Care News Small Cap Newly Approved Drugs In US Command Over $200,000 On An Average By Vandana Singh January 5, 2:13 PM The median annual price of 17 new drugs approved by the FDA since July 2022 reached $193,900, down from $257,000 in 1H of 2022. For the full year 2022, the median price was $222,003. BLUE
Read More Analyst Ratings Initiation News Price Target Jefferies Initiates Coverage On Penumbra with Buy Rating, Announces Price Target of $230 By Benzinga Newsdesk October 12, 9:39 AM Jefferies analyst Matthew Taylor initiates coverage on Penumbra (NYSE:PEN) with a Buy rating and announces Price Target of $230. PEN
Read More Analyst Ratings News Price Target JP Morgan Maintains Overweight on Array Technologies, Raises Price Target to $28 By Benzinga Newsdesk July 20, 10:20 AM JP Morgan analyst Mark Strouse maintains Array Technologies (NASDAQ:ARRY) with a Overweight and raises the price target from $26 to $28. ARRY